Search
forResearch 10 of 1000+
- CD80CD86 deficiency disrupts regulatory CD4+FoxP3+T cell homoeostasis and induces autoimmune-like alopecia
- Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers
- CD4+ Treg expansion arrests disease progression in a pre-clinical model of alopecia areata
- A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Skin CD4+ memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation
- Human T‐lymphotropic virus 1 (HTLV‐1)‐associated lichenoid dermatitis induced by CD8<sup>+</sup> T cells in HTLV‐1 carrier, HTLV‐1‐associated myelopathy/tropical spastic paraparesis and adult T‐cell leukemia/lymphoma
- CD4 T cells from mice with alopecia areata express an effector like phenotype and can transfer disease
- 039 Expansion of regulatory T Cells restrains pathogenic CD8 T Cells in a murine model of alopecia areata
- 0036 IL-27 generates immunosuppressive CD4 T cells and and prevents the development of alopecia areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →